Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein prenyltransferases.

Sebastian Maurer-Stroh1, Stefan Washietl, Frank Eisenhaber

  • 1Research Institute of Molecular Pathology, Dr Bohr-Gasse 7, A-1030 Vienna, Austria. stroh@imp.univie.ac.at

Genome Biology
|April 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.

Nature communications·2026
Same author

Central Nervous System Involvement by Novel Clade 2.3.2.1e H5N1 Avian Influenza Virus in a Pediatric Patient.

Open forum infectious diseases·2026
Same author

Secure bioinformatics: privacy-preserving federated analytics using homomorphic encryption.

Bioinformatics (Oxford, England)·2026
Same author

Fish size matters - Variable food allergen profiles in farmed and wild Malabar red snapper (Lutjanus malabaricus).

Food chemistry·2026
Same author

Research Priorities for Zoonotic and Pandemic Influenza Vaccines: Evidence and Recommendations from the WHO Public Health Research Agenda for Influenza (2024 Update).

Vaccines·2025
Same author

Fish isoallergens and variants: database compilation, <i>in silico</i> allergenicity prediction challenges, and epitope-based threshold optimization.

Frontiers in bioinformatics·2025
Same journal

Integrated lipidomic and transcriptomic profiling of the host response in human malaria.

Genome biology·2026
Same journal

Centromeric satellite expansion drives genome evolution in the snowy owl.

Genome biology·2026
Same journal

Mapping the landscape of allele-specific expression in porcine genomes.

Genome biology·2026
Same journal

Genomic sequence evolution underlying human neocortical interareal diversification.

Genome biology·2026
Same journal

Regulatory mechanisms driven by functional 3'-UTR variants in alcohol use disorder and related traits.

Genome biology·2026
Same journal

A longitudinal single-nucleus transcriptomic atlas of bovine placentation reveals dynamic cellular hierarchies and regulatory programs.

Genome biology·2026
See all related articles

Three enzymes, farnesyltransferase and two geranylgeranyltransferases, attach prenyl lipids to proteins. Farnesyltransferase-inhibitor drugs show potential for cancer and other diseases, but face challenges due to overlapping enzyme specificities.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • Protein prenyltransferases are crucial enzymes involved in post-translational modification.
  • These enzymes attach prenyl lipid anchors to specific protein targets.
  • Three main types exist: farnesyltransferase (FTase) and geranylgeranyltransferases I and II (GGTase-I, GGTase-II).

Purpose of the Study:

  • To elucidate the substrate specificities and structural characteristics of different protein prenyltransferases.
  • To understand the implications of these enzymes in disease and drug development.

Main Methods:

  • Analysis of protein substrate motifs recognized by FTase, GGTase-I, and GGTase-II.
  • Comparison of gene structures and potential alternative splicing of prenyltransferase subunits.

Related Experiment Videos

  • Review of existing literature on farnesyltransferase inhibitors (FTIs).

    • Main Results:

    • FTase and GGTase-I recognize a 'CaaX' motif, while GGTase-II recognizes a non-CaaX motif.
    • Genes for CaaX prenyltransferases are longer due to extensive introns, with predicted alternative splice forms.
    • FTIs are developed as anti-cancer agents, but their efficacy is complicated by overlapping substrate specificities.

    Conclusions:

    • Protein prenyltransferases exhibit distinct substrate specificities, with FTase and GGTase-I sharing the CaaX motif.
    • The genetic basis and alternative splicing of these enzymes warrant further investigation.
    • FTIs hold therapeutic promise but require careful consideration of enzyme cross-reactivity for optimal treatment strategies.